Partnership: Ehrfeld and Taros Collaborate to Promote Early Adoption of Flow Chemistry with a Comprehensive Market Offering

+++ 15.05.2024 Germany +++ Ehrfeld Mikrotechnik, a leading provider of reactors, mixers, and heat exchangers for micro reaction technology located in Wendelsheim, and Taros, with HQ in Dortmund, a globally active custom research and manufacturing organization serving the chemical, pharmaceutical and biotech industries, are jointly paving the way for a smooth access and deployment of flow chemistry as a high-performance and forward-looking research and production tool in chemical synthesis processes.

This collaboration comes at a time when the industry worldwide is facing stricter regulations in international chemical laws and regulations as well as increasing demands on product quality and production safety and must strive for innovative solutions beyond traditional production methods.

The partnership of key players within their respective markets, will as a premiere, combine both, high-performance flow chemistry hardware with strong chemical synthesis research and scale-up expertise. This unique combination of strengths will allow customers to validate flow chemistry as an alternative to conventional batch chemistry very quickly early on in their chemical R&D agenda and will contribute to preparing planned large-scale flow reactor syntheses at a commercial production scale.

Experience "Made in Germany": Research directors, product managers, or production managers can access through this partnership a combination of practice-tested, state-of-the-art flow chemistry equipment from laboratory to thousand-ton scale at Ehrfeld, as well as over 200 man-years of expertise in research and synthesis of organic molecules at Taros. From development to production, customers now consistently have first-class resources and expertise available from a single source to meet their challenges.

Dr. Rafael Kuwertz, Managing Director of Ehrfeld Mikrotechnik, welcomes this close collaboration of the two German companies: "This partnership strengthens our position as a pioneer in the industry and allows us to offer our customers even greater added value. The combination of our strengths opens up exciting new possibilities for innovation and growth; this is particularly important for medium-sized companies that want to act quickly and flexibly in global competition."

Dr. Alexander Piechot, Managing Director of Taros, also expressed optimism about the collaboration: "Through close collaboration with the experts at Ehrfeld, we can now offer our customers a unique service that enables the integration of both batch and flow chemistry processes in the development of new manufacturing processes. This specialized approach, which is rare to find in the contract synthesis and research industry, allows our customers to comprehensively evaluate the respective advantages of both methods directly in the laboratory environment. This enables them to design optimal and future-proof production processes that remain efficient and sustainable even under increasingly stringent regulations."

ACHEMA 2024: From June 10-14, 2024, interested parties can turn to the booth staff on-site in Frankfurt/Main in Hall 09 - Booth F34, Flowchemistry Pavilion (FCP) - Booth E64-005 for further discussions.

Ehrfeld Mikrotechnik GmbH:

Frau Anne Lakmanaarachchi
Head of Marketing
Mikroforum Ring 1
55234 Wendelsheim
Germany
Tel.: +49 6734 91546-63
Fax: +49 6734 91546-99
E-Mail: anne.lakmanaarachchi@ehrfeld.com
Web: www.ehrfeld.com

Taros Chemicals GmbH Co. KG:
Herr Youri R. Mesmoudi
Executive Vice President
Emil Figge Str 76a
44227 Dortmund
Germany
Tel: + 49 (0)231 22 61 98 11
Fax: + 49 (0)231 22 61 98 19
E-Mail: YMesmoudi@taros.de
Web: www.tarosdiscovery.com

An overview of the team players:

Ehrfeld: Developer and manufacturer of high-performance flow reactors for the chemical and pharmaceutical industry

Taros Chemicals: Globally active custom research and manufacturing organization serving the chemical, pharmaceutical and biotech industries

This release was published on openPR.